Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

BiPhoMag Bioorthogonal photocatalytic magnetic nanorobots for targeted therapy

Coordinator
Universidad De Santiago De Compostela, Spain
Runs
1 May 2026 to 30 April 2028
Status
Running
EU funding
€194k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101281360

What the project is doing

In the project's own words, from its summary on CORDIS.

Bioorthogonal chemistry enables the manipulation of biological systems without interfering with native processes and has revolutionized medicine and chemical biology. However, current bioorthogonal transformations remain restricted to a narrow range of stoichiometric, bond-cleaving reactions. There is therefore an unmet need for catalytic, bond-forming, and stimuli-responsive processes capable of inducing amplified and controllable biological effects.

BiPhoMag project aims to address this challenge by developing visible-light-driven catalytic bioorthogonal reactions mediated by multifunctional hybrid nanorobots. Specifically, core–shell iron oxide–silica nanoparticles will be engineered and functionalized with tunable, biocompatible organic photocatalysts. This design will enable spatiotemporal control of reactivity through the combined application of external light and magnetic fields.

The proposed methodology involves: (i) the fabrication and characterization of hybrid nanorobots; (ii) demonstration of efficient bond-forming photocatalysis under biologically relevant conditions; and (iii) validation of their functionality in living cells. By integrating heterogeneous catalysis, external actuation, and nanoparticle-mediated targeting, this project will establish a robust platform for photocatalytic bioorthogonal transformations under physiological conditions.

The expected impact of BiPhoMag is the creation of a new generation of photocatalytic tools with high precision and controllability, paving the way for innovative therapeutic strategies and advanced molecular manipulation in living systems.

Topics

Who is involved

OrganisationCityCountryRole
Universidad De Santiago De CompostelaSantiago De CompostelaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS